Literature DB >> 15761406

Treatment of biofilm infections on implants with low-frequency ultrasound and antibiotics.

John C Carmen1, Beverly L Roeder, Jared L Nelson, Rachel L Robison Ogilvie, Richard A Robison, G Bruce Schaalje, William G Pitt.   

Abstract

Medical implants are sometimes colonized by biofilm-forming bacteria, which are very difficult to treat effectively. The combination of gentamicin and ultrasonic exposure for 24 hours was previously shown to reduce the viability of Escherichia coli biofilms in vivo. This article shows that such treatment for 48 hours reduced viable E coli bacteria to nearly undetectable levels. However, when Pseudomonas aeruginosa biofilms were implanted and treated for 24 and 48 hours, no significant ultrasonic-enhanced reduction of viable bacteria was observed. The difference in response of these 2 organisms is attributed to greater impermeability and stability of the outer membrane of P aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761406      PMCID: PMC1361257          DOI: 10.1016/j.ajic.2004.08.002

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  21 in total

Review 1.  Role of biofilms in antimicrobial resistance.

Authors:  R M Donlan
Journal:  ASAIO J       Date:  2000 Nov-Dec       Impact factor: 2.872

Review 2.  Battling biofilms.

Authors:  J W Costerton; P S Stewart
Journal:  Sci Am       Date:  2001-07       Impact factor: 2.142

Review 3.  Molecular basis of bacterial outer membrane permeability.

Authors:  H Nikaido; M Vaara
Journal:  Microbiol Rev       Date:  1985-03

Review 4.  New concepts in the prevention of polymer-associated foreign body infections.

Authors:  B Jansen
Journal:  Zentralbl Bakteriol       Date:  1990-04

5.  Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis.

Authors:  Sang Sun Yoon; Robert F Hennigan; George M Hilliard; Urs A Ochsner; Kislay Parvatiyar; Moneesha C Kamani; Holly L Allen; Teresa R DeKievit; Paul R Gardner; Ute Schwab; John J Rowe; Barbara H Iglewski; Timothy R McDermott; Ronald P Mason; Daniel J Wozniak; Robert E W Hancock; Matthew R Parsek; Terry L Noah; Richard C Boucher; Daniel J Hassett
Journal:  Dev Cell       Date:  2002-10       Impact factor: 12.270

Review 6.  Outer membrane barrier as a mechanism of antimicrobial resistance.

Authors:  H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

7.  In vitro bioactivity and gentamicin release from glass-polymer-antibiotic composites.

Authors:  C V Ragel; M Vallet-Regí
Journal:  J Biomed Mater Res       Date:  2000-09-05

8.  Ultrasonically enhanced vancomycin activity against Staphylococcus epidermidis biofilms in vivo.

Authors:  J C Carmen; B L Roeder; J L Nelson; B L Beckstead; C M Runyan; G B Schaalje; R A Robison; W G Pitt
Journal:  J Biomater Appl       Date:  2004-04       Impact factor: 2.646

9.  Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes.

Authors:  F Yoshimura; H Nikaido
Journal:  J Bacteriol       Date:  1982-11       Impact factor: 3.490

Review 10.  Aminoglycoside uptake and mode of action-with special reference to streptomycin and gentamicin. II. Effects of aminoglycosides on cells.

Authors:  R E Hancock
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

View more
  36 in total

1.  Effective prevention of microbial biofilm formation on medical devices by low-energy surface acoustic waves.

Authors:  Zadik Hazan; Jona Zumeris; Harold Jacob; Hanan Raskin; Gera Kratysh; Moshe Vishnia; Naama Dror; Tilda Barliya; Mathilda Mandel; Gad Lavie
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

2.  Effect of delayed pulsed-wave ultrasound on local pharmacokinetics and pharmacodynamics of vancomycin-loaded acrylic bone cement in vivo.

Authors:  Xun-Zi Cai; Shi-Gui Yan; Hao-Bo Wu; Rong-Xin He; Xue-Song Dai; Hai-Xiang Chen; Rui-Jian Yan; Xin-Hua Zhao
Journal:  Antimicrob Agents Chemother       Date:  2007-07-09       Impact factor: 5.191

3.  Histotripsy Treatment of S. Aureus Biofilms on Surgical Mesh Samples Under Varying Scan Parameters.

Authors:  Timothy A Bigelow; Clayton L Thomas; Huaiqing Wu; Kamal M F Itani
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2018-06       Impact factor: 2.725

4.  Enhancement of vancomycin activity against biofilms by using ultrasound-targeted microbubble destruction.

Authors:  Nianan He; Jian Hu; Huayong Liu; Tao Zhu; Beijian Huang; Xueqin Wang; Yang Wu; Wenping Wang; Di Qu
Journal:  Antimicrob Agents Chemother       Date:  2011-08-15       Impact factor: 5.191

Review 5.  Medically important biofilms and non-thermal plasma.

Authors:  Jaroslav Julák; Vladimír Scholtz; Eva Vaňková
Journal:  World J Microbiol Biotechnol       Date:  2018-11-19       Impact factor: 3.312

6.  Increased temperature enhances the antimicrobial effects of daptomycin, vancomycin, tigecycline, fosfomycin, and cefamandole on staphylococcal biofilms.

Authors:  Stefan Hajdu; Johannes Holinka; Sonja Reichmann; Alexander M Hirschl; Wolfgang Graninger; Elisabeth Presterl
Journal:  Antimicrob Agents Chemother       Date:  2010-08-02       Impact factor: 5.191

Review 7.  Antibiofilm Peptides: Potential as Broad-Spectrum Agents.

Authors:  Daniel Pletzer; Robert E W Hancock
Journal:  J Bacteriol       Date:  2016-09-09       Impact factor: 3.490

8.  Impact of High-Intensity Ultrasound on Strength of Surgical Mesh When Treating Biofilm Infections.

Authors:  Timothy A Bigelow; Clayton L Thomas; Huaiqing Wu; Kamal M F Itani
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2018-11-14       Impact factor: 2.725

9.  A novel canine model of acute pyogenic spondylodiscitis.

Authors:  Wei-Hua Chen; Lei-Sheng Jiang; Li-Yang Dai
Journal:  Neurosurg Rev       Date:  2009-07-15       Impact factor: 3.042

10.  Therapeutic ultrasound as a treatment modality for chronic rhinosinusitis.

Authors:  Jim Bartley; Noureddin Nakhostin Ansari; Soofia Naghdi
Journal:  Curr Infect Dis Rep       Date:  2014-03       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.